Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare OTCMKTS:HCYTD OTCMKTS:MAGAA NYSE:SONX On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeHCYTDH-CYTE$2.02-49.5%$2.02$2.02▼$77.00$521K1.12103 shs400 shsMAGAAMagna-Lab$0.04$0.08$0.11▼$2.00$1.38M7.513,117 shs20,000 shsSONXSonendo$0.02$1.09$0.01▼$17.00$9K1.46981 shs13 shsThe Next 7 Blockbuster Stocks for Growth InvestorsWondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceHCYTDH-CYTE0.00%0.00%0.00%0.00%0.00%MAGAAMagna-Lab0.00%-68.15%-45.95%-55.06%-66.94%SONXSonendo0.00%-98.09%-98.09%-98.07%-70.19%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationHCYTDH-CYTEN/AN/AN/AN/AN/AN/AN/AN/AMAGAAMagna-LabN/AN/AN/AN/AN/AN/AN/AN/ASONXSonendoN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceHCYTDH-CYTE 0.00N/AN/AN/AMAGAAMagna-Lab 0.00N/AN/AN/ASONXSonendo 0.00N/AN/AN/ACompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookHCYTDH-CYTE$1.61M0.32N/AN/A($31.45) per share-0.06MAGAAMagna-LabN/AN/AN/AN/A($1.52) per shareN/ASONXSonendo$44.40M0.00N/AN/A$89.42 per share0.00Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateHCYTDH-CYTE-$4.80MN/A0.00∞N/A-450.40%N/A-777.68%N/AMAGAAMagna-Lab-$130K$0.180.22∞N/AN/A-12.32%42,399.99%N/ASONXSonendo-$60.92M-$59.12N/A∞N/A-92.74%-184.01%-68.60%8/8/2025 (Estimated)Compare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthHCYTDH-CYTEN/AN/AN/AN/AN/AMAGAAMagna-LabN/AN/AN/AN/AN/ASONXSonendoN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioHCYTDH-CYTEN/A0.120.12MAGAAMagna-LabN/AN/AN/ASONXSonendo0.551.821.22Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipHCYTDH-CYTEN/AMAGAAMagna-LabN/ASONXSonendo28.68%Insider OwnershipCompanyInsider OwnershipHCYTDH-CYTE5.24%MAGAAMagna-Lab15.30%SONXSonendo7.90%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableHCYTDH-CYTE8258,000244,000Not OptionableMAGAAMagna-Lab201.18 millionN/ANot OptionableSONXSonendo250429,000393,000Not OptionableMAGAA, HCYTD, and SONX HeadlinesRecent News About These CompaniesSonendo, Inc. Reports First Quarter 2025 Financial Results and Issues Financial GuidanceJune 4, 2025 | businesswire.comSonendo Inc. Reports Fourth Quarter and Full Year 2024 Financial ResultsMarch 26, 2025 | businesswire.comSonendo, Inc. to Release Third Quarter 2024 Financial Results and Postpone Conference Call on November 12, 2024November 11, 2024 | businesswire.comSonendo, Inc. (SONX) May Report Negative Earnings: Know the Trend Ahead of Next Week's ReleaseNovember 5, 2024 | zacks.comSonendo Launches ProControlTM for the GentleWave® G4 SystemOctober 23, 2024 | businesswire.comSonendo, Inc. Announces Preliminary Third Quarter 2024 Financial ResultsOctober 10, 2024 | businesswire.comBIOLASE files for Chapter 11, plans asset sale to SonendoOctober 3, 2024 | investing.comHere's Why Sonendo (SONX) Is a Great 'Buy the Bottom' Stock NowAugust 27, 2024 | zacks.comSonendo Inc.August 17, 2024 | marketwatch.comSonendo, Inc. (SONX) Q2 2024 Earnings Call TranscriptAugust 10, 2024 | seekingalpha.comSonendo, Inc. (SONX) Reports Q2 Loss, Tops Revenue EstimatesAugust 7, 2024 | zacks.comSonendo, Inc. Reports Second Quarter 2024 Financial Results and Raises Full Year Revenue GuidanceAugust 7, 2024 | finance.yahoo.comHere's what Wall Street expects from Sonendo's earnings reportAugust 7, 2024 | markets.businessinsider.comSonendo, Inc. (SONX)July 28, 2024 | finance.yahoo.comSonendo Strengthens Leadership With Key Strategic AppointmentsJune 5, 2024 | businesswire.comSonendo to Present at the 2024 Stifel Jaws & Paws ConferenceMay 20, 2024 | businesswire.comSonendo, Inc. (SONX) Q1 2024 Earnings Call TranscriptMay 12, 2024 | seekingalpha.comSonendo, Inc. (NYSE:SONX) Q1 2024 Earnings Call TranscriptMay 12, 2024 | msn.comSonendo Inc (SONX) Q1 2024 Earnings Call Transcript Highlights: Strategic Shifts and Financial ...May 9, 2024 | finance.yahoo.comSONX Stock Earnings: Sonendo Misses EPS, Beats Revenue for Q1 2024May 8, 2024 | investorplace.comMedia Sentiment Over TimeMAGAA, HCYTD, and SONX Company DescriptionsH-CYTE OTCMKTS:HCYTD$2.02 -1.98 (-49.50%) As of 07/11/2022H-CYTE, Inc., a biopharmaceutical company, develops and delivers various treatments for patients with chronic respiratory and pulmonary disorders in the United States. The company develops and implements treatment options in autologous cellular therapy to treat chronic lung disorders. It has a product supply agreement with Rion, LLC to develop and distribute a biologic for chronic obstructive pulmonary disease. The company is headquartered in Tampa, Florida.Magna-Lab OTCMKTS:MAGAA$0.04 0.00 (0.00%) As of 08/1/2025Magna-Lab Inc. does not have significant operations. It intends to identify and merge with an operating company. Previously, the company was engaged in the research, development, and commercialization of disposable medical devices to enhance the effectiveness of magnetic resonance imaging in detection and diagnosis of heart disease. The company was founded in 1991 and is based in Plainview, New York. Magna-Lab Inc. is a subsidiary of Magna Acquisition LLC.Sonendo NYSE:SONX$0.02 0.00 (0.00%) As of 08/1/2025Sonendo, Inc., a commercial-stage medical technology company, develops, manufactures, and commercializes devices for root canal therapy in the United States and Canada. It provides GentleWave, a tooth decay treatment, a technology platform designed for cleaning and disinfecting the microscopic spaces within teeth without the need to remove tooth structure. The company also offers SoundSeal, a material used to build and create a sealing platform on the top of the crown; and Sonendo-branded liquid solution of ethylenediaminetetraacetic acid EDTA that is used to help debride and disinfect the root canal system. In addition, it provides The Digital Office, a practice management software to enable an integrated digital office for dental practitioners. The company was formerly known as Dentatek Corporation and changed its name to Sonendo, Inc. in March 2011. The company was incorporated in 2006 and is headquartered in Laguna Hills, California. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 07/28 - 08/01 Alphabet Gains Momentum as Sentiment on Wall Street Improves Amazon's Earnings: What Comes Next and How to Play It Apple Stock: Big Earnings, Small Move—Time to Buy? Tesla Teams With Samsung—Will Other Chipmakers Follow? Will Hims & Hers Fall Along With Novo Nordisk? UPS's 7.5% Dividend: A Blue-Chip Stock on a Once-in-a-Decade Sale Is PG&E an AI Power Play? Why Options Traders Are Betting Big Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
